Critical dialogue: recent advancements toward omission of axillary lymph node dissection in clinically node positive breast cancer patients treated with neoadjuvant chemo-immuno th... by Florien J. G. van Amstel, Janine M. Simons, Vivianne C. G. Tjan-Heijnen, Marjolein L. Smidt, Thiemo J. A. van Nijnatten

Get full text

The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study by Tim C. de Ruijter, Kim M. Smits, Maureen J. Aarts, Irene E. G. van Hellemond, Leander Van Neste, Bart de Vries, Petronella G. M. Peer, Jürgen Veeck, Manon van Engeland, Vivianne C. G. Tjan-Heijnen

Get full text

Interval breast cancer characteristics before, during and after the transition from screen-film to full-field digital screening mammography by Rob M. G. van Bommel, Roy Weber, Adri C. Voogd, Joost Nederend, Marieke W. J. Louwman, Dick Venderink, Luc J. A. Strobbe, Matthieu J. C. Rutten, Menno L. Plaisier, Paul N. Lohle, Marianne J. H. Hooijen, Vivianne C.G. Tjan-Heijnen, Lucien E. M. Duijm

Get full text

Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trialResearc... by Vivianne C.G. Tjan-Heijnen, Senna W.M. Lammers, Sandra M.E. Geurts, Ingeborg J.H. Vriens, Astrid C.P. Swinkels, Carolien H. Smorenburg, Maurice J.C. van der Sangen, Judith R. Kroep, Hiltje de Graaf, Aafke H. Honkoop, Frans L.G. Erdkamp, Wilfred K. de Roos, Sabine C. Linn, Alexander L.T. Imholz

Get full text

Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands. by Paul P Schneider, Xavier G L V Pouwels, Valéria Lima Passos, Bram L T Ramaekers, Sandra M E Geurts, Khava I E Ibragimova, Maaike de Boer, Frans Erdkamp, Birgit E P J Vriens, Agnes J van de Wouw, Marien O den Boer, Manon J Pepels, Vivianne C G Tjan-Heijnen, Manuela A Joore

Get full text

Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study by Anouk H. Eijkelboom, Linda de Munck, Marie-Jeanne T. F. D. Vrancken Peeters, Mireille J. M. Broeders, Luc J. A. Strobbe, Monique E. M. M. Bos, Marjanka K. Schmidt, Cristina Guerrero Paez, Marjolein L. Smidt, Maud Bessems, Janneke Verloop, Sabine Linn, Marc B. I. Lobbes, Aafke H. Honkoop, Desirée H. J. G. van den Bongard, Pieter J. Westenend, Jelle Wesseling, C. Willemien Menke-van der Houven van Oordt, Vivianne C. G. Tjan-Heijnen, Sabine Siesling, the NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium

Get full text

Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC by Judith L. Gulikers, MSc, G.D. Marijn Veerman, MD, PhD, Merel Jebbink, MD, PhD, Paul D. Kruithof, PharmD, Christi M.J. Steendam, MD, PhD, René J. Boosman, PhD, Ron H.J. Mathijssen, MD, PhD, Vivianne C.G. Tjan-Heijnen, MD, PhD, Johanna H.M. Driessen, PhD, Safiye Dursun, MD, Egbert F. Smit, MD, PhD, Anne-Marie C. Dingemans, MD, PhD, Robin M.J.M. van Geel, PharmD, PhD, Sander Croes, PharmD, PhD, Lizza E.L. Hendriks, MD, PhD

Get full text